Browsing Tag
Mead Johnson
2 posts
Why Abbott Laboratories (NYSE: ABT) faces more than a legal bill after $70m Chicago baby formula ruling
Abbott was ordered to pay $70 million in a Chicago baby formula case. Read what the NEC verdict could mean for litigation risk, strategy, and ABT stock.
April 11, 2026
Reckitt Benckiser to sell 92% stake in Chinese infant formula business for $1.3bn
Reckitt Benckiser Group has agreed to divest 92% stake in Infant Formula and Child Nutrition business in China…
June 6, 2021